A hemoglobin-based oxygen carrier sensitized Cisplatin based chemotherapy in hepatocellular carcinoma

BACKGROUND AND OBJECTIVE: Our previous study showed that liver graft injury not only promotes tumor recurrence, but also induces chemoresistance in recurrent HCC after liver transplantation. Recently, we found that the hemoglobin-based oxygen carrier“YQ23” significantly ameliorates hepatic IR injury...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Xiang, Wong, Bing L., Lau, Sze Hang, Ng, Kevin Tak-Pan, Kwok, Sui Yi, Kin-Wai Sun, Chris, Tzang, Fei Chuen, Shao, Yan, Li, Chang Xian, Geng, Wei, Ling, Chang Chun, Ma, Yuen Yuen, Liu, Xiao Bing, Liu, Hui, Liu, Jiang, Yeung, Wai Ho, Lo, Chung Mau, Man, Kwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689611/
https://www.ncbi.nlm.nih.gov/pubmed/29156721
http://dx.doi.org/10.18632/oncotarget.19672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689611/
https://www.ncbi.nlm.nih.gov/pubmed/29156721
http://dx.doi.org/10.18632/oncotarget.19672

Ejemplares similares